Navigator

      Support By : Li-lab

Drug-Pathway
DRUGs and PATHWAYs
PATHWAY_NAME REACTOME_ID KEGG_ID DRUG_NAME PUBCHEM_CID Datasource
Graft-versus-host disease R-HSA-1643685 map05332 doxorubicin 4044 drug-path
Natural killer cell mediated cytotoxicity R-HSA-5218921 map04650 doxorubicin 4044 drug-path
Hematopoietic cell lineage R-HSA-173752 map04640 doxorubicin 4044 drug-path
PPAR signaling pathway R-HSA-168638 map03320 doxorubicin 4044 drug-path
Alzheimer's disease R-HSA-1643685 0 doxorubicin 4044 drug-path
Neuroactive ligand-receptor interaction R-HSA-5632681 map04080 doxorubicin 4044 drug-path
Taste transduction R-HSA-162582 map04742 doxorubicin 4044 drug-path
Autoimmune thyroid disease R-HSA-1643685 map05320 doxorubicin 4044 drug-path
Antigen processing and presentation R-HSA-1236975 map04612 doxorubicin 4044 drug-path
Leukocyte transendothelial migration R-HSA-8950732 map04670 doxorubicin 4044 drug-path
Huntington's disease R-HSA-1643685 0 doxorubicin 4044 drug-path
Cell adhesion molecules (CAMs) R-HSA-1031690 0 doxorubicin 4044 drug-path
Focal adhesion R-HSA-354113 map04510 doxorubicin 4044 drug-path
Primary immunodeficiency R-HSA-5601905 map05340 doxorubicin 4044 drug-path
Tight junction R-HSA-2134514 map04530 doxorubicin 4044 drug-path
Long-term potentiation R-HSA-9620244 map04720 doxorubicin 4044 drug-path
Vibrio cholerae infection R-HSA-9609646 map05110 doxorubicin 4044 drug-path
Asthma R-HSA-444620 map05310 doxorubicin 4044 drug-path
ECM-receptor interaction R-HSA-373711 map04512 doxorubicin 4044 drug-path
Chemokine signaling pathway R-HSA-168638 map04062 doxorubicin 4044 drug-path